Alta Wealth Advisors LLC Biogen Inc. Transaction History

Alta Wealth Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$212.02 - $267.71 $23,746 - $29,983	-112 Reduced 9.22%	1,103 $237,000
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $160,264 - $192,916	-720 Reduced 37.21%	1,215 $314,000
Q3 2023 Oct 19, 2023	BUY	$253.3 - $285.89 $31,662 - $35,736	125 Added 6.91%	1,935 $497,000
Q2 2023 Jul 17, 2023	BUY	$275.25 - $318.06 $72,115 - $83,331	262 Added 16.93%	1,810 $515,000
Q1 2023 Apr 21, 2023	BUY	$256.56 - $292.34 $397,154 - $452,542	1,548 New	1,548 $430,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Alta Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alta Wealth Advisors LLC with notifications on news.